James Brady is in his 22nd year of practice. He joined Dickstein Shapiro in 1988, and is a partner in the Intellectual Property Practice. He focuses on patent law involving pharmaceutical, biotechnology, and chemical inventions. Mr. Brady has served as lead intellectual property counsel to a wide range of pharmaceutical, biotechnology, and chemical companies in business transactions and in developing strategies to position the companies and their intellectual property portfolios to succeed in these highly competitive industries. His technical expertise encompasses pharmaceutical compounds and formulations, drug delivery technology, antibodies, vaccines, biological materials and genomics, polymer chemistry, medical devices, alternative energy, and environmental processes, among others.

Bar Admissions

District of Columbia
New York
U.S. Patent and Trademark Office
U.S. District Courts
U.S. Court of Appeals for the Federal Circuit

Education

The Pennsylvania State University, B.S., 1982, with Highest Distinction
Cornell University Law School, J.D., 1985